Literature DB >> 14527531

Attentional bias to threat in social phobia: facilitated processing of threat or difficulty disengaging attention from threat?

N Amir1, J Elias, H Klumpp, A Przeworski.   

Abstract

There is a growing body of research pointing to the possibility that anxious individuals may have difficulty disengaging their attention from threat-relevant information when this information is task irrelevant (e.g., Amir, N., & Elias, J. (2002). Allocation of attention to threat in social phobia: difficulty in disengaging from task irrelevant cues, Manuscript under review; The Quarterly J. Expo. Psycho. 54A (2001) 665). In the current paper, we report a direct test of this hypothesis in individuals with social phobia. Participants performed a variation of the Posner paradigm (Quart. J. Exp. Psycho. 32 (1980) 3). Social threat, neutral, or positive words cued one of two locations on the computer screen. After the cue disappeared, participants had to detect a probe ("(*)") that appeared in one of the two locations. On some trials the cue was valid (i.e., the probe appeared in the same location as the cue). On other trials the cue was invalid (the probe appeared in a different location than the cue). Yet, on other trials, no cue was presented. All participants were slower in detecting probes following invalid cues than probes following valid cues. Furthermore, individuals with social phobia showed significantly longer response latencies when detecting invalidly cued targets than did controls, but only when the probe followed a social threat word. These results suggest that individuals with social phobia may have difficulty disengaging their attention from socially threatening material.

Entities:  

Mesh:

Year:  2003        PMID: 14527531     DOI: 10.1016/s0005-7967(03)00039-1

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  85 in total

1.  Automatic emotional information processing and the cortisol response to acute psychosocial stress.

Authors:  Mark A Ellenbogen; Robyn J Carson; Rana Pishva
Journal:  Cogn Affect Behav Neurosci       Date:  2010-03       Impact factor: 3.282

2.  Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder.

Authors:  Izelle Labuschagne; K Luan Phan; Amanda Wood; Mike Angstadt; Phyllis Chua; Markus Heinrichs; Julie C Stout; Pradeep J Nathan
Journal:  Neuropsychopharmacology       Date:  2010-08-18       Impact factor: 7.853

3.  Faces retain attention.

Authors:  Markus Bindemann; A Mike Burton; Ignace T C Hooge; Rob Jenkins; Edward H F de Haan
Journal:  Psychon Bull Rev       Date:  2005-12

4.  Commitment to a purpose in life: an antidote to the suffering by individuals with social anxiety disorder.

Authors:  Todd B Kashdan; Patrick E McKnight
Journal:  Emotion       Date:  2013-06-24

Review 5.  An evolutionary perspective on the co-occurrence of social anxiety disorder and alcohol use disorder.

Authors:  Adam Bulley; Beyon Miloyan; Ben Brilot; Matthew J Gullo; Thomas Suddendorf
Journal:  J Affect Disord       Date:  2016-02-17       Impact factor: 4.839

6.  Psychological treatment of social anxiety disorder improves body dysmorphic concerns.

Authors:  Angela Fang; Alice T Sawyer; Idan M Aderka; Stefan G Hofmann
Journal:  J Anxiety Disord       Date:  2013-08-06

7.  Insula activation is modulated by attention shifting in social anxiety disorder.

Authors:  Elizabeth R Duval; Sonalee A Joshi; Stefanie Russman Block; James L Abelson; Israel Liberzon
Journal:  J Anxiety Disord       Date:  2018-04-20

Review 8.  Mechanisms of attentional biases towards threat in anxiety disorders: An integrative review.

Authors:  Josh M Cisler; Ernst H W Koster
Journal:  Clin Psychol Rev       Date:  2009-12-14

9.  Changes in Decentering Across Cognitive Behavioral Group Therapy for Social Anxiety Disorder.

Authors:  Sarah A Hayes-Skelton; Carol S Lee
Journal:  Behav Ther       Date:  2018-01-31

10.  The effects of emotion priming on visual search in socially anxious adults.

Authors:  Sara A Haas; Dima Amso; Nathan A Fox
Journal:  Cogn Emot       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.